Company news
22nd Century Group, Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
22nd Century Group’s (Nasdaq: XXII) VLN® Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden’s Cancer Moonshot Initiative
September 12, 2022
22nd Century Group (Nasdaq: XXII) Appoints Accomplished Media Executive Lucille S. Salhany to Its Board
September 11, 2022
22nd Century Group (Nasdaq: XXII) Launches VLN® Reduced Nicotine Content Cigarettes in Colorado with Circle K, Smoker Friendly and New Distribution Points
September 6, 2022
22nd Century Group (Nasdaq: XXII) Announces Management Updates and Departure of Chief Operating Officer
September 6, 2022
22nd Century Group (Nasdaq: XXII) VLN® Reduced Nicotine Content Cigarettes Awarded Best New Product by Convenience Store News
August 23, 2022
22nd Century Group (Nasdaq: XXII) to Ring the Nasdaq Stock Market Closing Bell
August 21, 2022
22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Second Quarter 2022
August 8, 2022
22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2022 Results on August 9, 2022
July 26, 2022
22nd Century Announces $35 Million Registered Direct Offering Priced Above Market under Nasdaq Rules
July 20, 2022
22nd Century Group (Nasdaq: XXII) Appoints R. Hugh Kinsman as CFO
June 15, 2022
22nd Century Group (Nasdaq: XXII) Announces John J. Miller Joins Its Tobacco Business
May 22, 2022
22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform
May 17, 2022
22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company
May 12, 2022
22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the First Quarter 2022
May 4, 2022
22nd Century Group (Nasdaq: XXII) Issues Annual Letter to Shareholders
April 27, 2022
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022
April 13, 2022
22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer
April 10, 2022
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2021
February 28, 2022
22nd Century Group Announces South Korea as First VLN® International Market
February 27, 2022
22nd Century Secures USDA Organic Certification for Needle Rock Farms
February 9, 2022
22nd Century Group to Announce Fourth Quarter and Full Year 2021 Results on March 1, 2022
February 2, 2022
22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale
January 25, 2022
22nd Century Group Appoints James A. Mish to Its Board of Directors
January 20, 2022
22nd Century Launching the First Reduced Nicotine Cigarette Authorized by the FDA That Helps You Smoke Less
January 17, 2022
FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product
December 22, 2021
22nd Century Ready to Provide Full Commercial Support to New Zealand’s Plan to Reduce Nicotine Content of All Cigarettes
December 9, 2021
22nd Century Group Announces CFO Transition
November 18, 2021
22nd Century Group Reports Business Highlights and Financial Results for the Third Quarter 2021
November 3, 2021
22nd Century Group Enters Global Specialty Hops Market
August 29, 2021
22nd Century Group Appoints Accomplished Life Sciences and Biotechnology Executive Anthony Johnson to Board of Directors
August 18, 2021
22nd Century Group to Begin Trading on Nasdaq on August 16, 2021
August 4, 2021
22nd Century Group Secures New Contract Manufacturing Agreements, Expands Distribution Network and Manufacturing Capabilities Ahead of VLN® Launch
July 21, 2021
22nd Century Group Adds Strategic Partnerships With Sawatch Agriculture and Folium Botanical for Next-Generation Commercial Hemp/Cannabis Plant Breeding and Commercial Scale-Up
July 13, 2021
22nd Century Announces Restructuring of Panacea Investment, Expansion of Cannabis Franchise Capabilities
June 30, 2021
22nd Century Announces Closing of $40 Million Common Stock Registered Direct Offering
June 8, 2021
22nd Century Announces $40 Million Common Stock Registered Direct Offering
June 6, 2021
22nd Century Group Reports Business Highlights and Financial Results for the First Quarter 2021
May 5, 2021
22nd Century Group Installs State-of-the-Art Nicotine Testing Equipment to Enhance VLN® Production
May 4, 2021
22nd Century Group and KeyGene Extend and Expand Plant Research Partnership
May 3, 2021
22nd Century Delivers 3.6 Million Variable Nicotine Content Research Cigarettes for Independent Scientific Studies
April 25, 2021
22nd Century Group Issues Annual Letter to Shareholders
April 20, 2021
22nd Century Stands Fully Prepared to Enable New Zealand Proposal to Advance Nationwide Smoke-Free Action Plan
April 14, 2021
22nd Century Group Receives Additional $3.7 Million from Cash Exercise of Outstanding Warrants
March 11, 2021
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020
March 10, 2021
22nd Century Group to Participate in Investor Conferences in March 2021
March 4, 2021
22nd Century Group Receives $8.1 Million from Cash Exercise of Outstanding Warrants
March 3, 2021
22nd Century Group Secures Exclusive Agreement with CannaMetrix to Accelerate Commercialization of New, Disruptive Hemp/Cannabis Plant Lines and Intellectual Property
March 2, 2021
22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with Commercially Valuable Traits
February 9, 2021
22nd Century Group to Relocate Headquarters to Buffalo’s Thriving Larkinville District
January 27, 2021
22nd Century Group Expands VLN® Tobacco Growing Program to Support Anticipated Demand of the Company’s Reduced Nicotine Content Cigarettes
January 10, 2021
Calls
The 5 newest of 19 calls. Every call is listed under its year.
- 22nd Century Group (NASDAQ:XXII) Q2 2026 Earnings Call
Aug 13, 2026
Transcript - 22nd Century Group (NASDAQ:XXII) Q1 2026 Earnings Call
May 7, 2026
Transcript - 22nd Century Group (NASDAQ:XXII) Q4 2025 Earnings Call
Mar 26, 2026
Transcript - 22nd Century Group (NASDAQ:XXII) Q3 2025 Earnings Call
Nov 4, 2025
Transcript - 22nd Century Group (NASDAQ:XXII) Q2 2025 Earnings Call
Aug 14, 2025
Transcript
Decks
The 5 newest of 16 decks. Every deck is listed under its year.
- Investor Presentation (September 2026)
Investor deck · 14 slides · September 2026
- Q1 2026 Earnings Presentation
Earnings · 16 slides · May 7, 2026
- Q1 2025 Earnings Presentation
Earnings · 16 slides · May 13, 2025
- Q2 2023 Earnings Presentation
Earnings · 20 slides · Aug 14, 2023
- Q1 2023 Earnings Presentation
Earnings · 28 slides · May 9, 2023